CellSeed Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on CellSeed's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs Industry Growth | 31.9% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 31 Dec 2021 |
Recent past performance updates
Revenue & Expenses Breakdown
How CellSeed makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 21 | 161 | -914 | 387 | 541 |
| 30 Sep 21 | 244 | -875 | 393 | 539 |
| 30 Jun 21 | 222 | -929 | 392 | 576 |
| 31 Mar 21 | 209 | -847 | 395 | 500 |
| 31 Dec 20 | 199 | -783 | 402 | 438 |
| 30 Sep 20 | 148 | -836 | 390 | 507 |
| 30 Jun 20 | 171 | -803 | 377 | 519 |
| 31 Mar 20 | 189 | -812 | 407 | 503 |
| 31 Dec 19 | 275 | -782 | 423 | 546 |
| 30 Sep 19 | 693 | -332 | 416 | 513 |
| 30 Jun 19 | 841 | -149 | 417 | 482 |
| 31 Mar 19 | 1,032 | 87 | 406 | 463 |
| 31 Dec 18 | 1,026 | 129 | 391 | 432 |
| 30 Sep 18 | 586 | -388 | 389 | 492 |
| 30 Jun 18 | 406 | -617 | 394 | 539 |
| 31 Mar 18 | 184 | -843 | 384 | 611 |
| 31 Dec 17 | 85 | -966 | 394 | 632 |
| 30 Sep 17 | 106 | -1,399 | 370 | 1,110 |
| 30 Jun 17 | 98 | -1,357 | 361 | 1,082 |
| 31 Mar 17 | 105 | -1,419 | 367 | 1,085 |
| 31 Dec 16 | 100 | -1,414 | 373 | 1,065 |
| 30 Sep 16 | 190 | -775 | 392 | 495 |
| 30 Jun 16 | 192 | -685 | 385 | 402 |
| 31 Mar 16 | 182 | -582 | 372 | 336 |
| 31 Dec 15 | 193 | -535 | 363 | 302 |
| 30 Sep 15 | 72 | -593 | 302 | 301 |
| 30 Jun 15 | 81 | -586 | 310 | 284 |
| 31 Mar 15 | 89 | -574 | 345 | 243 |
| 31 Dec 14 | 86 | -582 | 328 | 248 |
| 30 Sep 14 | 67 | -694 | 386 | 243 |
| 30 Jun 14 | 92 | -660 | 371 | 239 |
| 31 Mar 14 | 92 | -610 | 318 | 255 |
| 31 Dec 13 | 105 | -584 | 295 | 228 |
Quality Earnings: Insufficient data to determine if 7776 has high quality earnings.
Growing Profit Margin: Insufficient data to determine if 7776's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if 7776's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare 7776's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if 7776's earnings growth over the past year exceeded the Biotechs industry average.
Return on Equity
High ROE: 7776 has a negative Return on Equity (0%), as it is currently unprofitable.